Fundz

Sofie Biosciences, Inc. reported raising $3.7 Million in an initial SEC Form D filing, from an offering of $4 Million

PRIVATEJun 13, 2016$3.7M of $4M raised

Amount Raised

$3.7 Million

$3.7 Million sold, per SEC Form D (first sale Jun 13, 2016)

Round Type

Seed

Los AngelesBiotechnology

Quick answer

SOFIE Biosciences raised $3.7 Million in a Seed round, dated June 13, 2016. SOFIE Biosciences is based in Los Angeles, California, United States.

How much did SOFIE Biosciences raise?
SOFIE Biosciences raised $3.7 Million in a Seed round on June 13, 2016.
What does SOFIE Biosciences do?
SOFIE Biosciences is a leading innovator in the field of radiopharmaceuticals.
Where is SOFIE Biosciences based and how big is it?
SOFIE Biosciences is based in Los Angeles, California, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as SOFIE Biosciences that raised within 45 days of this round, from Fundz verified event records.

  • Prairie Plant Systems Inc. raised $6.5M on July 28, 2016.
  • Ceapro Inc. raised $7.7M on July 27, 2016.
  • Invenra raised $3M (Seed) on July 20, 2016.
  • Sonomotion Inc. raised $100K (Pre-Seed) on July 20, 2016.
  • RIVANNA raised $170K on July 20, 2016.
  • Laxmi Therapeutic Devices raised $1.5M (Seed) on July 19, 2016.

Who to call at SOFIE Biosciences, and when

A new round usually means SOFIE Biosciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day SOFIE Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at SOFIE Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at SOFIE Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

SOFIE Biosciences

Location

6162 BRISTOL PARKWAY

Los Angeles, California, United States

About

SOFIE Biosciences is a leading innovator in the field of radiopharmaceuticals. The company develops advanced imaging agents for cancer diagnosis and treatment. Its products aim to improve the accuracy and effectiveness of diagnostic imaging. SOFIE is dedicated to pioneering new solutions in PET imaging.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment SOFIE Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for SOFIE Biosciences's next move

See what Strategic adds

SOFIE Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.